Astrana Health, Inc.(ASTH)Earnings, Financials & Key Ratios

ASTH•NASDAQ

$35.25

$1.96B mkt cap·76.6× P/E·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare Facilities Sub-IndustryPhysician platforms and value-based care

AboutAstrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Show more

Revenue$3.18B+56.4%
EBITDA$124M+6.0%
Net Income$22M-47.9%
EPS (Diluted)0.46-48.9%
Gross Margin9.3%-30.3%
EBITDA Margin3.91%-32.2%
Operating Margin2.47%-43.8%
Net Margin0.71%-66.7%
ROE4.19%-55.1%
ROIC6.18%-47.6%
Debt/Equity1.93+110.4%
Interest Coverage1.57-54.3%

Technical→

ASTH Key Insights

Astrana Health, Inc. (ASTH) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Momentum leader: RS Rating 87 (top 13%)
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 53.8%
✓Trading near 52-week high
✓Efficient asset utilization: 1.4x turnover

✗Weaknesses

✗Weak Piotroski F-Score: 3/9

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ASTH Price & Volume

Astrana Health, Inc. (ASTH) stock price & volume — 10-year historical chart

Loading chart...

ASTH Growth Metrics

Astrana Health, Inc. (ASTH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years53.76%

3 Years40.62%

TTM56.39%

Profit CAGR

10 Years-

5 Years-

3 Years-20.75%

TTM-47.89%

EPS CAGR

10 Years-

5 Years-14.55%

3 Years-22.55%

TTM-49.17%

Return on Capital

10 Years4.87%

5 Years10.87%

3 Years9.2%

Last Year6.06%

ASTH Recent Earnings

Astrana Health, Inc. (ASTH) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)

Q2 2026Latest

Mar 2, 2026

EPS

$0.54

Est $0.15

+260.0%

Revenue

$951M

Est $930M

+2.2%

Q4 2025

Nov 6, 2025

EPS

$0.01

Est $0.47

-97.9%

Revenue

$956M

Est $930M

+2.7%

Q3 2025

Aug 7, 2025

EPS

$0.19

Est $0.36

-47.2%

Revenue

$655M

Est $944M

-30.6%

Q2 2025

May 8, 2025

EPS

$0.14

Est $0.23

-39.1%

Revenue

$620M

Est $631M

-1.6%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Mar 2, 2026	$0.54vs $0.15+260.0%	$951Mvs $930M+2.2%
Q4 2025	Nov 6, 2025	$0.01vs $0.47-97.9%	$956Mvs $930M+2.7%
Q3 2025	Aug 7, 2025	$0.19vs $0.36-47.2%	$655Mvs $944M-30.6%
Q2 2025	May 8, 2025	$0.14vs $0.23-39.1%	$620Mvs $631M-1.6%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
ALHCAlignment Healthcare, Inc.Direct Competitor	3.71B	18.14	-4902.70	46.06%	0.47%	11.5%	1.89
CLOVClover Health Investments, Corp.Direct Competitor	1.37B	2.68	-15.76	40.34%	-2.58%	-17.08%
OSCROscar Health, Inc.Direct Competitor	5.14B	19.84	-11.74	27.5%	-0.3%	-3.26%	0.44
WELLWelltower Inc.Product Competitor	151.66B	216.47	155.73	35.82%	12.31%	3.49%	0.49
AGLAgilon Health, Inc.Product Competitor	463.98M	27.85	-1.14	-2.11%	-6.42%	-146.01%	0.29
DOCSDoximity, Inc.Product Competitor	5.17B	25.69	23.14	19.98%	37.54%	24.45%	0.01
PRVAPrivia Health Group, Inc.Product Competitor	3.01B	23.99	133.28	22.26%	1.08%	3.06%	0.01
UNHUnitedHealth Group IncorporatedSupply Chain	333.37B	367.28	27.76	11.81%	2.68%	11.54%	0.77

Compare ASTH vs Peers

Astrana Health, Inc. (ASTH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ALHC

Most directly comparable listed peer for ASTH.

Scale Benchmark

vs UNH

Larger-name benchmark to compare ASTH against a more recognizable public peer.

Peer Set

Compare Top 5

vs ALHC, CLOV, OSCR, WELL

ASTH Income Statement

Astrana Health, Inc. (ASTH) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	357.75M	519.91M	560.62M	370.25M	773.91M	1.14B	1.39B	2.03B	3.18B
Revenue Growth %	712.16%	45.33%	7.83%	-33.96%	109.03%	47.84%	21.19%	46.72%	56.39%
Cost of Goods Sold	293.73M	380.44M	467.81M	348.54M	596.14M	944.68M	1.17B	1.76B	2.89B
COGS % of Revenue	82.11%	73.17%	83.44%	94.14%	77.03%	82.57%	84.5%	86.66%	90.7%
Gross Profit	64.02M▲ 0%	139.47M▲ 117.9%	92.81M▼ 33.5%	21.7M▼ 76.6%	177.77M▲ 719.0%	199.48M▲ 12.2%	214.96M▲ 7.8%	271.39M▲ 26.3%	295.78M▲ 9.0%
Gross Margin %	17.89%	26.83%	16.56%	5.86%	22.97%	17.43%	15.5%	13.34%	9.3%
Gross Profit Growth %	560.19%	117.87%	-33.45%	-76.61%	719.04%	12.21%	7.76%	26.25%	8.99%
Operating Expenses	26.44M	47.24M	60.39M	15.62M	79.59M	95.21M	130.34M	182.04M	217.26M
OpEx % of Revenue	7.39%	9.09%	10.77%	4.22%	10.28%	8.32%	9.4%	8.95%	6.83%
Selling, General & Admin	26.44M	47.24M	41.48M	15.59M	62.08M	77.67M	112.6M	154.11M	217.26M
SG&A % of Revenue	7.39%	9.09%	7.4%	4.21%	8.02%	6.79%	8.12%	7.57%	6.83%
Research & Development	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	18.91M	26K	17.52M	17.54M	17.75M	27.93M	0
Operating Income	37.58M▲ 0%	92.23M▲ 145.4%	32.42M▼ 64.8%	6.09M▼ 81.2%	98.18M▲ 1513.2%	104.27M▲ 6.2%	84.61M▼ 18.8%	89.35M▲ 5.6%	78.53M▼ 12.1%
Operating Margin %	10.5%	17.74%	5.78%	1.64%	12.69%	9.11%	6.1%	4.39%	2.47%
Operating Income Growth %	670.91%	145.44%	-64.85%	-81.23%	1513.19%	6.2%	-18.85%	5.6%	-12.12%
EBITDA	56.65M	111.53M	50.7M	24.44M	115.7M	121.81M	102.36M	117.28M	124.27M
EBITDA Margin %	15.84%	21.45%	9.04%	6.6%	14.95%	10.65%	7.38%	5.76%	3.91%
EBITDA Growth %	1009.26%	96.87%	-54.54%	-51.8%	373.47%	5.28%	-15.97%	14.57%	5.97%
D&A (Non-Cash Add-back)	19.08M	19.3M	18.28M	18.35M	17.52M	17.54M	17.75M	27.93M	45.75M
EBIT	49.79M	83.19M	30.57M	11.39M	83.14M	94.54M	105.94M	113.92M	78.53M
Net Interest Income	935.51K	698K	-2.71M	-2.12M	-3.82M	-5.94M	-1.89M	-18.59M	-37.77M
Interest Income	1.02M	1.26M	2.02M	405K	1.57M	1.98M	14.21M	14.51M	12.16M
Interest Expense	79.69K	560.51K	4.73M	2.53M	5.39M	7.92M	16.1M	33.1M	49.93M
Other Income/Expense	12.13M	-9.6M	-6.58M	2.78M	-20.43M	-17.65M	5.22M	-8.53M	-38.92M
Pretax Income	49.71M▲ 0%	82.63M▲ 66.2%	25.84M▼ 68.7%	8.87M▼ 65.7%	77.75M▲ 776.7%	86.62M▲ 11.4%	89.84M▲ 3.7%	80.82M▼ 10.0%	39.61M▼ 51.0%
Pretax Margin %	13.9%	15.89%	4.61%	2.4%	10.05%	7.57%	6.48%	3.97%	1.24%
Income Tax	3.89M	22.36M	8.17M	9.18M	31.69M	40.88M	31.99M	30.89M	15.53M
Effective Tax Rate %	7.82%	27.06%	31.61%	103.54%	40.76%	47.19%	35.61%	38.22%	39.21%
Net Income	25.8M▲ 0%	10.84M▼ 58.0%	14.12M▲ 30.3%	-23.75M▼ 268.3%	68.92M▲ 390.2%	45.17M▼ 34.5%	60.72M▲ 34.4%	43.15M▼ 28.9%	22.49M▼ 47.9%
Net Margin %	7.21%	2.08%	2.52%	-6.42%	8.91%	3.95%	4.38%	2.12%	0.71%
Net Income Growth %	376.13%	-58.01%	30.28%	-268.26%	390.18%	-34.46%	34.42%	-28.93%	-47.89%
Net Income (Continuing)	45.82M	60.27M	17.67M	-314K	46.05M	45.74M	57.85M	49.93M	24.08M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	176.37M	226.12M	169.51M	114.32M	62.48M	15.99M	-203.45M	-198.55M	-220.96M
EPS (Diluted)	0.90▲ 0%	0.29▼ 67.8%	0.39▲ 34.5%	1.01▲ 159.0%	1.52▲ 50.5%	0.99▼ 34.9%	1.29▲ 30.3%	0.90▼ 30.2%	0.46▼ 48.9%
EPS Growth %	150.28%	-67.78%	34.48%	158.97%	50.5%	-34.87%	30.3%	-30.23%	-48.89%
EPS (Basic)	1.01	0.33	0.41	1.04	1.57	1.00	1.30	0.91	0.46
Diluted Shares Outstanding	28.66M	37.91M	36.4M	37.45M	45.4M	45.6M	47.07M	48.22M	49.37M
Basic Shares Outstanding	25.53M	32.89M	34.71M	36.53M	43.83M	44.97M	46.71M	47.69M	49.08M
Dividend Payout Ratio	40.49%	163.9%	437.21%	-	45.11%	31.06%	102.24%	9.35%	35.06%

ASTH Balance Sheet

Astrana Health, Inc. (ASTH) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	144.16M	172.86M	329.07M	338.58M	404.46M	428.13M	461.51M	638.5M	863.31M
Cash & Short-Term Investments	120.92M	108.02M	219.73M	261.17M	286.51M	293.59M	296.31M	290.83M	429.47M
Cash Only	119.77M	106.89M	103.19M	193.47M	233.1M	288.03M	293.81M	288.45M	429.47M
Short-Term Investments	1.14M	1.13M	116.54M	67.69M	53.42M	5.57M	2.5M	2.38M	0
Accounts Receivable	20.12M	57.46M	98.95M	60.62M	99.31M	119.73M	147.75M	324.8M	407.57M
Days Sales Outstanding	20.53	40.34	64.42	59.76	46.84	38.2	38.89	58.27	46.76
Inventory	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-
Other Current Assets	0	0	75K	0	0	14.8M	17.45M	22.86M	26.26M
Total Non-Current Assets	346.48M	340.14M	399.64M	478.91M	462.9M	538.09M	471.85M	716.4M	1.36B
Property, Plant & Equipment	13.81M	12.72M	26.38M	48.46M	68.63M	128.98M	44.57M	46.88M	94.43M
Fixed Asset Turnover	25.90x	40.87x	21.25x	7.64x	11.28x	8.87x	31.11x	43.40x	33.69x
Goodwill	189.85M	185.81M	238.5M	239.05M	246.42M	269.05M	278.83M	419.25M	863.94M
Intangible Assets	0	0	103.01M	86.98M	82.81M	76.86M	71.65M	118.18M	270.97M
Long-Term Investments	37.65M	53.53M	29.32M	80.37M	42.61M	42.7M	32.17M	48.22M	25.64M
Other Non-Current Assets	1.63M	1.21M	2.43M	19.41M	22.44M	4.56M	2.22M	63.22M	100.37M
Total Assets	490.64M▲ 0%	513M▲ 4.6%	728.71M▲ 42.0%	817.49M▲ 12.2%	867.36M▲ 6.1%	966.21M▲ 11.4%	933.36M▼ 3.4%	1.35B▲ 45.2%	2.22B▲ 63.8%
Asset Turnover	0.73x	1.01x	0.77x	0.45x	0.89x	1.18x	1.49x	1.50x	1.43x
Asset Growth %	2407.53%	4.56%	42.05%	12.18%	6.1%	11.4%	-3.4%	45.16%	63.75%
Total Current Liabilities	109.6M	72.02M	105.42M	114.99M	114.72M	148.61M	218.67M	365.61M	615.27M
Accounts Payable	27.18M	4.48M	6.91M	9.55M	5.51M	10.47M	9.07M	15.17M	3.52M
Days Payables Outstanding	33.78	4.3	5.39	10.01	3.38	4.05	2.83	3.14	0.45
Short-Term Debt	5.54M	40.26K	9.5M	10.89M	780K	619K	19.5M	9.38M	55.67M
Deferred Revenue (Current)	250K	9.02M	8.89M	12.99M	16.8M	531K	744K	1.61M	0
Other Current Liabilities	68.99M	41.75M	61.96M	67.09M	65.89M	113.24M	164M	257.74M	556.08M
Current Ratio	1.32x	2.40x	3.12x	2.94x	3.53x	2.88x	2.11x	1.75x	1.40x
Quick Ratio	1.32x	2.40x	3.12x	2.94x	3.53x	2.88x	2.11x	1.75x	1.40x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	44.72M	34.32M	262.23M	257.35M	242M	259.06M	303.92M	475.12M	1.05B
Long-Term Debt	0	13M	232.17M	230.21M	182.92M	203.39M	258.94M	425.3M	990.9M
Capital Lease Obligations	520.26K	517.26K	11.79M	16.18M	14.17M	21.19M	37.32M	31.26M	31.55M
Deferred Tax Liabilities	24.92M	19.62M	18.27M	10.96M	30.14M	14.22M	4.07M	4.55M	5.49M
Other Non-Current Liabilities	19.28M	1.19M	0	0	14.78M	20.26M	3.59M	14M	17.11M
Total Liabilities	154.32M	106.34M	367.65M	372.34M	356.72M	407.67M	522.59M	840.73M	1.66B
Total Debt	6.25M	13.66M	256.55M	260.56M	200.98M	229.36M	321.01M	471.84M	1.08B
Net Debt	-113.52M	-93.23M	153.36M	67.08M	-32.11M	-58.66M	27.21M	183.38M	648.66M
Debt / Equity	0.02x	0.03x	0.71x	0.59x	0.39x	0.41x	0.78x	0.92x	1.93x
Debt / EBITDA	0.11x	0.12x	5.06x	10.66x	1.74x	1.88x	3.14x	4.02x	8.68x
Net Debt / EBITDA	-2.00x	-0.84x	3.02x	2.75x	-0.28x	-0.48x	0.27x	1.56x	5.22x
Interest Coverage	624.81x	148.41x	6.46x	4.51x	15.41x	11.94x	6.58x	3.44x	1.57x
Total Equity	336.31M▲ 0%	406.66M▲ 20.9%	361.06M▼ 11.2%	445.15M▲ 23.3%	510.64M▲ 14.7%	558.55M▲ 9.4%	410.77M▼ 26.5%	514.17M▲ 25.2%	558.33M▲ 8.6%
Equity Growth %	3832.9%	20.92%	-11.21%	23.29%	14.71%	9.38%	-26.46%	25.17%	8.59%
Book Value per Share	11.73	10.73	9.92	11.89	11.25	12.25	8.73	10.66	11.31
Total Shareholders' Equity	159.95M	180.55M	191.55M	330.82M	448.17M	542.56M	614.22M	712.72M	779.29M
Common Stock	32.3K	34.58K	36K	42K	45K	47K	47K	48K	49K
Retained Earnings	1.73M	17.79M	31.91M	69.77M	137.25M	182.42M	243.13M	286.28M	308.38M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0	0	0
Minority Interest	176.37M	226.12M	169.51M	114.32M	62.48M	15.99M	-203.45M	-198.55M	-220.96M

ASTH Cash Flow Statement

Astrana Health, Inc. (ASTH) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	53.07M	26.1M	13.67M	46.16M	70.33M	82.13M	68.23M	52.2M	114.6M
Operating CF Margin %	14.84%	5.02%	2.44%	12.47%	9.09%	7.18%	4.92%	2.57%	3.6%
Operating CF Growth %	2985.82%	-50.82%	-47.62%	237.62%	52.36%	16.77%	-16.93%	-23.49%	119.54%
Net Income	25.8M	10.84M	17.67M	122.08M	46.05M	45.74M	57.85M	49.93M	24.08M
Depreciation & Amortization	19.08M	19.3M	18.28M	18.35M	17.52M	17.54M	17.75M	27.93M	45.75M
Stock-Based Compensation	0	0	1.55M	3.38M	6.75M	16.1M	22.04M	34.54M	38.6M
Deferred Taxes	-20.68M	-8.35M	-6.8M	396K	7.67M	-14.28M	-12.44M	-4.25M	-4.29M
Other Non-Cash Items	42.15M	157.26M	5.75M	-102.08M	25.98M	18.98M	6.42M	7.67M	13.56M
Working Capital Changes	15.98M	-63.05M	-22.77M	4.04M	-33.64M	-1.96M	-23.39M	-63.61M	-3.1M
Change in Receivables	10.7M	-28.63M	-5.8M	3.01M	-21.63M	-33.97M	-20.57M	-11.1M	0
Change in Inventory	0	0	0	-7.71M	-2.11M	27.61M	12.15M	0	0
Change in Payables	-1.81M	-22.67M	-4.39M	15.82M	4.11M	-2.52M	-498K	-30.43M	0
Cash from Investing	6.73M	-25.76M	-180.63M	95.49M	16.54M	-7.11M	-65.52M	-192.4M	-539M
Capital Expenditures	-2.08M	-1.17M	-1.04M	-1.16M	-19.22M	-22.94M	-28.53M	-8.03M	-10.11M
CapEx % of Revenue	0.58%	0.23%	0.19%	0.31%	2.48%	2%	2.06%	0.39%	0.32%
Acquisitions	0	-16.68M	-53M	31.42M	-3.9M	-18.46M	-7.54M	-156.13M	-548.6M
Investments	-	-	-	-	-	-	-	-	-
Other Investing	26.8M	-7.5M	-11.19M	16.41M	56K	4.47M	-23.8M	-25.74M	4.61M
Cash from Financing	-14.98M	-11.2M	163.33M	-51.7M	-47.75M	-20.09M	3.42M	135.15M	569.35M
Debt Issued (Net)	4.9M	7.41M	234.48M	-9.61M	-58.69M	-828K	79.17M	152.71M	604.81M
Equity Issued (Net)	-425.28K	-850.97K	-6.82M	10.27M	43.46M	-9.25M	-8.67M	-937K	-15.43M
Dividends Paid	-10.45M	-17.76M	-61.72M	-51.32M	-31.09M	-14.03M	-62.07M	-4.04M	-7.88M
Share Repurchases	-3.18M	-5.05M	-7.57M	-537K	-5.74M	-9.25M	-10.19M	-937K	-15.43M
Other Financing	-9M	323	-2.62M	-1.04M	-1.42M	4.02M	-5.01M	-12.59M	-12.15M
Net Change in Cash	110.5M▲ 0%	-12.88M▼ 111.7%	-3.63M▲ 71.8%	89.96M▲ 2580.3%	39.13M▼ 56.5%	54.93M▲ 40.4%	6.13M▼ 88.8%	-5.05M▼ 182.5%	144.94M▲ 2969.6%
Free Cash Flow	50.99M▲ 0%	24.93M▼ 51.1%	12.63M▼ 49.3%	45M▲ 256.3%	51.11M▲ 13.6%	59.19M▲ 15.8%	39.7M▼ 32.9%	44.17M▲ 11.3%	104.49M▲ 136.6%
FCF Margin %	14.25%	4.8%	2.25%	12.15%	6.6%	5.17%	2.86%	2.17%	3.28%
FCF Growth %	2526.63%	-51.1%	-49.34%	256.26%	13.58%	15.8%	-32.93%	11.26%	136.58%
FCF per Share	1.78	0.66	0.35	1.20	1.13	1.30	0.84	0.92	2.12
FCF Conversion (FCF/Net Income)	2.06x	2.41x	0.97x	-1.94x	1.02x	1.82x	1.12x	1.21x	5.10x
Interest Paid	51.04K	462K	4.26M	8.51M	4.16M	6.67M	14.25M	30.42M	0
Taxes Paid	24.36M	23.64M	20.2M	62M	37.2M	47.31M	56.57M	43.94M	0

ASTH Key Ratios

Astrana Health, Inc. (ASTH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2015	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-109.27%	14.96%	2.92%	3.68%	-5.89%	14.42%	8.45%	12.53%	9.33%	4.19%
Return on Invested Capital (ROIC)	-	25.36%	25.8%	5.87%	0.89%	14.86%	15.98%	13.53%	11.8%	6.18%
Gross Margin	22.01%	17.89%	26.83%	16.56%	5.86%	22.97%	17.43%	15.5%	13.34%	9.3%
Net Margin	-21.21%	7.21%	2.08%	2.52%	-6.42%	8.91%	3.95%	4.38%	2.12%	0.71%
Debt / Equity	0.02x	0.02x	0.03x	0.71x	0.59x	0.39x	0.41x	0.78x	0.92x	1.93x
Interest Coverage	-14.20x	624.81x	148.41x	6.46x	4.51x	15.41x	11.94x	6.58x	3.44x	1.57x
FCF Conversion	0.20x	2.06x	2.41x	0.97x	-1.94x	1.02x	1.82x	1.12x	1.21x	5.10x
Revenue Growth	-	712.16%	45.33%	7.83%	-33.96%	109.03%	47.84%	21.19%	46.72%	56.39%

ASTH SEC Filings & Documents

Astrana Health, Inc. (ASTH) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Mar 30, 2026·SEC

Material company update

Mar 4, 2026·SEC

Material company update

Mar 2, 2026·SEC

10-K Annual Reports

FY 2026

Mar 12, 2026·SEC

FY 2025

Mar 14, 2025·SEC

10-Q Quarterly Reports

FY 2025

Nov 10, 2025·SEC

FY 2025

Aug 7, 2025·SEC

FY 2025

May 9, 2025·SEC

ASTH Frequently Asked Questions

Astrana Health, Inc. (ASTH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Astrana Health, Inc. (ASTH) reported $3.18B in revenue for fiscal year 2025. This represents a 7123% increase from $44.0M in 2015.

Astrana Health, Inc. (ASTH) grew revenue by 56.4% over the past year. This is strong growth.

Yes, Astrana Health, Inc. (ASTH) is profitable, generating $22.5M in net income for fiscal year 2025 (0.7% net margin).

Dividend & Returns

Yes, Astrana Health, Inc. (ASTH) pays a dividend with a yield of 0.45%. This makes it attractive for income-focused investors.

Astrana Health, Inc. (ASTH) has a return on equity (ROE) of 4.2%. This is below average, suggesting room for improvement.

Astrana Health, Inc. (ASTH) generated $107.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More ASTH

Astrana Health, Inc. (ASTH) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Astrana Health, Inc.(ASTH)Earnings, Financials & Key Ratios

ASTH Key Insights

✓Strengths

✗Weaknesses

ASTH Price & Volume

ASTH Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

ASTH Recent Earnings

ASTH Peer Comparison

Compare ASTH vs Peers

vs ALHC

vs UNH

Compare Top 5

ASTH Income Statement

ASTH Balance Sheet

ASTH Cash Flow Statement

ASTH Key Ratios

ASTH SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

ASTH Frequently Asked Questions

Explore More ASTH

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation